JO
PROF

John Overdeck’s Profound Medical PROF Stock Holding History

John Overdeck’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,617
Closed -$305K – 4606
2021
Q2 		$305K Sell
18,617
-32,973
-64% -$613K ﹤0.01% 3505
2021
Q1 		$1.04M Sell
51,590
-4,182
-7% -$100K ﹤0.01% 2278
2020
Q4 		$1.15M Buy
55,772
+13,064
+31% +$240K ﹤0.01% 1884
2020
Q3 		$753K Buy
+42,708
New +$679K ﹤0.01% 1960
2020
Q2 		– Sell
-14,500
Closed -$141K – 3414
2020
Q1 		$141K Buy
+14,500
New +$188K ﹤0.01% 2763

Other funds holding PROF

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

John Overdeck's PROF Position: Q3 2021 in Review

John Overdeck sold out of Profound Medical (PROF) in Q3 2021, closing a stake of 18,617 shares — an estimated $305K sold.

John Overdeck first reported a position in PROF in Q1 2020 and held it in 5 quarters. The position peaked at $1.15M in Q4 2020. 46 funds tracked by Wall St. Rank hold PROF as of Q3 2021.

  • John Overdeck reported no remaining Profound Medical position as of Q3 2021 after selling out during the quarter.
  • John Overdeck sold 18,617 Profound Medical shares in Q3 2021, an estimated $305K.
  • John Overdeck first reported a position in Profound Medical in Q1 2020 and held it in 5 quarters.
  • John Overdeck's Profound Medical position peaked at $1.15M in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Profound Medical as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.